William P. Mr. Burke

CIK 1682069 · Chief Financial Officer · last filed 2026-06-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.40M

Companies

4

Total Filings

60

Lifetime Open-Market Net

-$17.44M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AXGN Director 21,850 $42.38 $926.0K -$2.80M 15 2026-06-26
Miromatrix Medical Inc. (MIRO) Delisted Director 67,413 $3.39 $228.5K $50.0K 5 2023-12-13
ViewRay, Inc. (VRAY) Delisted Chief Financial Officer 356,318 $0.03 $8.9K $0 2 2023-03-03
HAE EVP, Chief Financial Officer 52,958 $84.45 $4.47M -$14.69M 26 2021-08-25

Recent Filings · Page 3 of 6

60 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-06-20 AXGN Grant (A) $0 EDGAR
2025-06-11 AXGN Sell (S) −4,073 -$43.2K EDGAR
2024-09-04 AXGN Exer (M) +11,904 $0 EDGAR
2024-06-10 AXGN Grant (A) +10,653 $0 EDGAR
2023-12-13 Miromatrix Medical Inc. (MIRO) Delisted Mixed −134,356 $0 EDGAR
2023-09-07 AXGN Grant (A) $0 EDGAR
2023-08-25 AXGN Mixed +16,000 $103.5K EDGAR
2023-06-05 Miromatrix Medical Inc. (MIRO) Delisted Grant (A) +54,201 $0 EDGAR
2023-03-30 Miromatrix Medical Inc. (MIRO) Delisted Buy (P) +31,250 $50.0K EDGAR
2023-03-03 ViewRay, Inc. (VRAY) Delisted Grant (A) +103,686 $0 EDGAR
Showing 2130 of 60
Page 3 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.